Sign inJoin waitlistJoin the waitlist

Mridula Krishnan

Physician · University of Nebraska Medical Center College of Medicine

Credentials: · · · · · ·

History

University of Nebraska Medical Center College of Medicine
2021–Present

Hematology and Medical Oncology
University of Nebraska Medical Center College of Medicine
2018–2021
CUMC School of Medicine
2015–2018
KASTURBA MED COLL, MANIPAL, KARNATAKA
2009–2013

Research

Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid Tumors
JCO Oncology Practice · 2022 · First of 5 authors · 24 citations
Colorectal cancer: Review of signaling pathways and associated therapeutic strategies
Review · Journal of Surgical Oncology · 2023 · 14 citations
Immune Checkpoint Inhibitor-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Squamous Cell Carcinoma
Case report · Journal of Hematology · 2022 · Last of 3 authors · 11 citations

Apar Ganti
3 papers
Benjamin Teply
2 papers
FD
Felicia D'Souza
2 papers · 2 as a resident
Manasa Velagapudi
2 papers · 1 as a fellow
Matthew Lunning
2 papers
Rosalyn Marar
2 papers · 2 as a resident
Sruti Prathivadhi-Bhayankaram
2 papers
AA
Aabra Ahmed
1 paper
Abd Abdelrahman
1 paper
AA
Abram Arnold
1 paper · 1 as a fellow
AT
Ashley Tuin
1 paper
AK
Avyakta Kallam
1 paper

Clinical trials

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Site PI · Recruiting · Phase 3
NRG Oncology
2026–2034
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2028